Cargando…
SUN-142 High Prevalence of NAFLD and Advanced Fibrosis in Patients with Obesity and Diabetes
Non-alcoholic fatty liver disease (NAFLD) is the most common, chronic liver disorder in the United States (US). Non-alcoholic steatohepatitis (NASH), the more severe form of NAFLD with hepatocyte necroinflammation that may lead to cirrhosis and hepatocellular carcinoma (HCC), is believed to be commo...
Autores principales: | Barb, Diana, Repetto, Enrico, Stokes, Michael, Shankar, Sudha, Cusi, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553053/ http://dx.doi.org/10.1210/js.2019-SUN-142 |
Ejemplares similares
-
MON-644 Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
por: Fanous, Nada, et al.
Publicado: (2020) -
SUN-LB026 Do CFTR Modulators Treat Cystic Fibrosis-Related Diabetes?
por: Mehfooz, Ayesha, et al.
Publicado: (2019) -
SUN-663 Dietary Coconut Oil Mitigates Features of Metabolic Syndrome in Obese Females
por: Skenandore, Cassandra, et al.
Publicado: (2020) -
Fetuin-A as a Marker of NAFLD
por: Dharmalingam, Mala, et al.
Publicado: (2021) -
MON-142 Neuropathy in a Patient with Diabetes Mellitus: Not Always a Diabetic Disease
por: Baranski Lamback, Elisa, et al.
Publicado: (2019)